FDA Suggests Alternative NDMA Test for Ranitidine By Sam | October 25, 2019 The FDA is recommending a second low-temperature test for determining if ranitidine products contain the probable carcinogen N-nitrosodimethylamine (NDMA). Source: Drug Industry Daily Posted in Drug Industry Daily